0585365 - FGÚ 2025 RIV GB eng J - Journal Article
Chvíla, S. - Kubová, Hana - Mareš, Pavel - Kudová, Eva - Štěpánek, F.
A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model.
RSC Pharmaceutics. Roč. 1, č. 1 (2024), s. 37-46. E-ISSN 2976-8713
R&D Projects: GA MŠMT(CZ) LX22NPO5104; GA MZd(CZ) EF16_025/0007444
Institutional support: RVO:67985823 ; RVO:61388963
Keywords : nanocrystal formulation * neuroactive steroids * zuranolone * solubility * epilepsy
OECD category: Neurosciences (including psychophysiology
Method of publishing: Open access
Result website:
https://doi.org/10.1039/D3PM00043EDOI: https://doi.org/10.1039/D3PM00043E
Permanent Link: https://hdl.handle.net/11104/0353090
Chvíla, S. - Kubová, Hana - Mareš, Pavel - Kudová, Eva - Štěpánek, F.
A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model.
RSC Pharmaceutics. Roč. 1, č. 1 (2024), s. 37-46. E-ISSN 2976-8713
R&D Projects: GA MŠMT(CZ) LX22NPO5104; GA MZd(CZ) EF16_025/0007444
Institutional support: RVO:67985823 ; RVO:61388963
Keywords : nanocrystal formulation * neuroactive steroids * zuranolone * solubility * epilepsy
OECD category: Neurosciences (including psychophysiology
Method of publishing: Open access
Result website:
https://doi.org/10.1039/D3PM00043EDOI: https://doi.org/10.1039/D3PM00043E
Permanent Link: https://hdl.handle.net/11104/0353090